#United States #Unisys Corporation #Exton #West Pharmaceutical #Janet Haugen

West Pharmaceutical Services Welcomes New Board Member

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the injectable drug administration industry, has recently announced the election of Janet Haugen as a new director on its Board of Directors. With this addition, the board now comprises 12 members, reflecting the company’s commitment to strengthening its governance and leadership team.

Who is Janet Haugen?

Janet Haugen, aged 66, brings a wealth of experience from her previous role as the Chief Financial Officer at Unisys Corporation. Over her more than 16-year term at Unisys, she guided the company through a significant transformation, shifting it from a mainframe hardware and software provider to a dynamic IT services and software firm. Her comprehensive approach encompassed not only financial oversight but also corporate development, IT management, procurement, facilities administration, and legal affairs.

Before her tenure at Unisys, Haugen was a partner at Ernst & Young, where she collaborated with numerous Fortune 500 companies, focusing on global clients in both the technology and manufacturing sectors. Her extensive background underscores her capabilities in financial strategy and operational leadership in complex corporate environments.

Currently, Haugen is also on the boards of Bentley Systems, Juniper Networks, and CentralSquare Technologies, further enhancing her qualifications for the position at West. She holds a degree in Economics from Rutgers University and is a certified director of the National Association of Corporate Directors (NACD).

A Vision for West

In a statement regarding her election, Paolo Pucci, the Lead Independent Director at West, expressed enthusiasm about welcoming Haugen to the Board. He highlighted her unique blend of technology and financial expertise, asserting that her insights will prove invaluable as the company continues its mission to enhance healthcare services.

Haugen’s extensive board experience and solid operational background are seen as key assets that will help West reinforce its commitment to delivering high-quality healthcare to millions of patients daily.

About West Pharmaceutical Services

West Pharmaceutical Services is renowned for its innovative solutions and services in injectable drug administration, positioning itself as a trusted partner for established and emerging pharmaceutical developers. The company is responsible for the safe containment and delivery of essential medicines across the globe. Operating with a workforce of approximately 10,000 across 50 locations worldwide, West delivers around 43 billion product components and devices every year.

In fiscal year 2023, the company achieved an impressive net sales figure of $2.95 billion, underlining its status as a leader in the healthcare sector.

Headquartered in Exton, Pennsylvania, West is publicly traded on the New York Stock Exchange (NYSE: WST) and is featured in the Standard & Poor’s 500 index. For further information about the company and its offerings, visit West Pharmaceutical's website.

The addition of Janet Haugen to the West Board marks a significant step forward in enhancing the company’s leadership capabilities, particularly in navigating the ever-evolving landscape of healthcare and technology.